SciMed Biotech Podcast with Dr. Charles “Chuck” Reynolds

Chuck Reynolds, Founder of Gfree Bio

How computers are designing the next generation of drugs

In this episode, we sit down with Dr. Charles Reynolds, founder of Gfree Bio, to explore how computational modeling is transforming drug discovery. They discuss how scientists use molecular simulations, docking, and structure-based design to understand how potential drugs interact with proteins and how those insights guide the development of better therapies. Dr. Reynolds also shares how advances in computing power and machine learning are expanding what’s possible in computational chemistry and accelerating the search for new medicines.